Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pittrow

Showing results (111-120 of 150) with videos related to

Pageof 15
Sort By:
Clinical and Experimental Rheumatology|June 26, 2010
Interactions between rheumatologists and cardio-/pulmonologists in the assessment and use of outcome measures in pulmonary arterial hypertension related to systemic sclerosisDoerte Huscher, David Pittrow, Oliver Distler, et al.
The Journal of Rheumatology|December 4, 2009
Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension: a systematic literature analysis by the EPOSS groupOtylia Kowal-Bielecka, Jerome Avouac, David Pittrow, et al.
Pneumologie (Stuttgart, Germany)|October 6, 2025
[Treatment Algorithm of Pulmonary Arterial Hypertension]Ekkehard Grünig, Katrin Milger, Albert Omlor, et al.
The European Respiratory Journal|October 20, 2018
Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patientsMarion Delcroix, Gerd Staehler, Henning Gall, et al.
Scientific Reports|July 5, 2017
Improved risk stratification in prevention by use of a panel of selected circulating microRNAsTill Keller, Jes-Niels Boeckel, Stefan Groß, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 7, 2025
Add-on therapy with parenteral prostacyclin analogues in patients with pulmonary arterial hypertension: Insights from the COMPERA registryKhodr Tello, Marion Delcroix, Christine Pausch, et al.
Plos One|December 3, 2015
Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial PneumoniasMarius M Hoeper, Juergen Behr, Matthias Held, et al.
Journal of the American College of Cardiology|July 23, 2016
Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological ContinuumChristian F Opitz, Marius M Hoeper, J Simon R Gibbs, et al.
ESC Heart Failure|March 4, 2025
Mono and combination therapies in pulmonary arterial hypertension patients with comorbidities: A COMPERA analysisDirk Skowasch, Christine Pausch, Doerte Huscher, et al.
The European Respiratory Journal|August 5, 2017
Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification modelMarius M Hoeper, Tilmann Kramer, Zixuan Pan, et al.
Pageof 15

Showing results (111-120 of 150) with videos related to

Sort By:
Pageof 15
Clinical and Experimental Rheumatology|June 26, 2010
Interactions between rheumatologists and cardio-/pulmonologists in the assessment and use of outcome measures in pulmonary arterial hypertension related to systemic sclerosisDoerte Huscher, David Pittrow, Oliver Distler, et al.
The Journal of Rheumatology|December 4, 2009
Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension: a systematic literature analysis by the EPOSS groupOtylia Kowal-Bielecka, Jerome Avouac, David Pittrow, et al.
Pneumologie (Stuttgart, Germany)|October 6, 2025
[Treatment Algorithm of Pulmonary Arterial Hypertension]Ekkehard Grünig, Katrin Milger, Albert Omlor, et al.
The European Respiratory Journal|October 20, 2018
Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patientsMarion Delcroix, Gerd Staehler, Henning Gall, et al.
Scientific Reports|July 5, 2017
Improved risk stratification in prevention by use of a panel of selected circulating microRNAsTill Keller, Jes-Niels Boeckel, Stefan Groß, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 7, 2025
Add-on therapy with parenteral prostacyclin analogues in patients with pulmonary arterial hypertension: Insights from the COMPERA registryKhodr Tello, Marion Delcroix, Christine Pausch, et al.
Plos One|December 3, 2015
Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial PneumoniasMarius M Hoeper, Juergen Behr, Matthias Held, et al.
Journal of the American College of Cardiology|July 23, 2016
Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological ContinuumChristian F Opitz, Marius M Hoeper, J Simon R Gibbs, et al.
ESC Heart Failure|March 4, 2025
Mono and combination therapies in pulmonary arterial hypertension patients with comorbidities: A COMPERA analysisDirk Skowasch, Christine Pausch, Doerte Huscher, et al.
The European Respiratory Journal|August 5, 2017
Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification modelMarius M Hoeper, Tilmann Kramer, Zixuan Pan, et al.
Pageof 15